_id
6915e9e4bc934aba376b1c2d
Ticker
PXMD
Name
PaxMedica, Inc. Common Stock
Exchange
PINK
Address
303 South Broadway, Tarrytown, NY, United States, 10591
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.paxmedica.com
Description
PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies for the treatment of disorders with intractable neurologic symptoms. Its lead product candidate is PAX-101 that is in Phase 3 clinical trials, an intravenous formulation of suramin for the treatment of autism spectrum disorder, myalgic encephalomyelitis/chronic fatigue syndrome, long COVID-19 syndrome, fragile X syndrome, human African trypanosomiasis (HAT), and fragile X-associated tremor/ataxia syndrome. The company is developing PAX-102, an intranasal formulation of suramin for neurologic indications, as well as other new chemical entities that are targeted and selective antagonists of purine receptor subtypes; and PAX-HAT-301 for the treatment of HAT. It has a research collaboration agreement with PolarMar Health for Phase II clinical trial in austism spectrum disorder for emodin, which retains the rights for PolarMar to develop and commercialize any non-prescription supplement form of the product, and for PaxMedica, Inc. to retain exclusive rights to develop and commercialize a highly purified form of emodin. The company was formerly known as Purinix Pharmaceuticals LLC and changed its name to PaxMedica, Inc. in April 2020. PaxMedica, Inc. was incorporated in 2018 and is based in Tarrytown, New York.
Last Close
0.0001
Volume
-
Current Price
0.0001
Change
0
Last Updated
2026-01-06T09:48:07.308Z
Image
-
Ipo Date
2022-08-26T00:00:00.000Z
Market Cap
12563
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4
Target Price
3
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2024-06-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
2999000
Operating Income
-2999000
Interest Expense
0
Pretax Income
-2998000
Net Income
-2998000
Eps
-0.39158829676071055
Dividends Per Share
-
Shares Outstanding
125633870
Income Tax Expense
-
EBITDA
-2998000
Operating Margin
-
Total Other Income Expense Net
729
Cash
324486
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
799611
Property Plant Equipment
-
Total Assets
799611
Payables
2042103
Short Term Debt
-
Long Term Debt
-
Total Liabilities
2607231
Equity
-1807620
Bs_currency_symbol
USD
Depreciation
729
Change In Working Capital
1695222
Cash From Operations
-1302406
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
0
Net Change In Cash
-1302406
Cf_currency_symbol
USD
PE
-
PB
-0.000423540345869154
ROE
165.85344264834424
ROA
-374.93231083614404
FCF
-1302406
Fcf Percent
-
Piotroski FScore
1
Health Score
39
Deep Value Investing Score
2
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
2
Growth Investing Score
2
Momentum Investing Score
2
Net Net Investing Score
2
Quality Investing Score
2.5
Value Investing Score
2.5
Quarters > 0 > quarter
2024-06-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
2999000
Quarters > 0 > income Statement > operating Income
-2999000
Quarters > 0 > income Statement > interest Expense
0
Quarters > 0 > income Statement > pretax Income
-2998000
Quarters > 0 > income Statement > net Income
-2998000
Quarters > 0 > income Statement > eps
-0.39158829676071055
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
7656000
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-2998000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
729
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
324486
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
799611
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
799611
Quarters > 0 > balance Sheet > payables
2042103
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
2607231
Quarters > 0 > balance Sheet > equity
-1807620
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-2997779
Quarters > 0 > cash Flow > depreciation
729
Quarters > 0 > cash Flow > change In Working Capital
1695222
Quarters > 0 > cash Flow > cash From Operations
-1302406
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
0
Quarters > 0 > cash Flow > net Change In Cash
-1302406
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.39158829676071055
Quarters > 0 > ratios > PB
-0.000423540345869154
Quarters > 0 > ratios > ROE
165.85344264834424
Quarters > 0 > ratios > ROA
-374.93231083614404
Quarters > 0 > ratios > FCF
-1302406
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
39
Quarters > 1 > quarter
2024-03-31
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
3690000
Quarters > 1 > income Statement > operating Income
-3690000
Quarters > 1 > income Statement > interest Expense
0
Quarters > 1 > income Statement > pretax Income
-3693000
Quarters > 1 > income Statement > net Income
-3693000
Quarters > 1 > income Statement > eps
-0.4978430843893233
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
7418000
Quarters > 1 > income Statement > income Tax Expense
-46298
Quarters > 1 > income Statement > EBITDA
-3693000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-3022
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
1626892
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
2893103
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
2893103
Quarters > 1 > balance Sheet > payables
1137967
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1703095
Quarters > 1 > balance Sheet > equity
1190008
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-3693185
Quarters > 1 > cash Flow > depreciation
43276
Quarters > 1 > cash Flow > change In Working Capital
-888685
Quarters > 1 > cash Flow > cash From Operations
-3068471
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-15279
Quarters > 1 > cash Flow > net Change In Cash
-3083750
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.4978430843893233
Quarters > 1 > ratios > PB
0.0006233571539014863
Quarters > 1 > ratios > ROE
-310.33404817446603
Quarters > 1 > ratios > ROA
-127.64841072025435
Quarters > 1 > ratios > FCF
-3068471
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
32
Quarters > 2 > quarter
2023-12-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
4386000
Quarters > 2 > income Statement > operating Income
-4386000
Quarters > 2 > income Statement > interest Expense
9174165
Quarters > 2 > income Statement > pretax Income
-5920000
Quarters > 2 > income Statement > net Income
-5920000
Quarters > 2 > income Statement > eps
-0.7998919064991218
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
7401000
Quarters > 2 > income Statement > income Tax Expense
193763
Quarters > 2 > income Statement > EBITDA
-5920000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-1534000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
4710642
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
0
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
5680405
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
5680405
Quarters > 2 > balance Sheet > payables
811733
Quarters > 2 > balance Sheet > short Term Debt
-500000000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
2295332
Quarters > 2 > balance Sheet > equity
3385073
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-5920473
Quarters > 2 > cash Flow > depreciation
43812
Quarters > 2 > cash Flow > change In Working Capital
1216957
Quarters > 2 > cash Flow > cash From Operations
-2617274
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
6174955
Quarters > 2 > cash Flow > net Change In Cash
3557681
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.7998919064991218
Quarters > 2 > ratios > PB
0.00021863634846279535
Quarters > 2 > ratios > ROE
-174.88544560191167
Quarters > 2 > ratios > ROA
-104.21792108133134
Quarters > 2 > ratios > FCF
-2617274
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
38
Quarters > 3 > quarter
2023-09-30
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
4365000
Quarters > 3 > income Statement > operating Income
-4365000
Quarters > 3 > income Statement > interest Expense
1309
Quarters > 3 > income Statement > pretax Income
-5049000
Quarters > 3 > income Statement > net Income
-5049000
Quarters > 3 > income Statement > eps
-5.195850317524186
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
971737
Quarters > 3 > income Statement > income Tax Expense
1309
Quarters > 3 > income Statement > EBITDA
-5048000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-685000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
1152961
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
500000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
3233577
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
3233577
Quarters > 3 > balance Sheet > payables
1644996
Quarters > 3 > balance Sheet > short Term Debt
1581268
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
3770496
Quarters > 3 > balance Sheet > equity
-536919
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-5049218
Quarters > 3 > cash Flow > depreciation
-326000
Quarters > 3 > cash Flow > change In Working Capital
1469124
Quarters > 3 > cash Flow > cash From Operations
-2331800
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
414867
Quarters > 3 > cash Flow > net Change In Cash
-1916933
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-5.195850317524186
Quarters > 3 > ratios > PB
-0.0001809839100497468
Quarters > 3 > ratios > ROE
940.3653064987456
Quarters > 3 > ratios > ROA
-156.1428721196372
Quarters > 3 > ratios > FCF
-2331800
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
39
Annuals > 0 > quarter
2023-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
16145000
Annuals > 0 > income Statement > operating Income
-16145000
Annuals > 0 > income Statement > interest Expense
9165
Annuals > 0 > income Statement > pretax Income
-18290000
Annuals > 0 > income Statement > net Income
-18290000
Annuals > 0 > income Statement > eps
-10.999551959201224
Annuals > 0 > income Statement > dividends Per Share
11945936005
Annuals > 0 > income Statement > shares Outstanding
1662795
Annuals > 0 > income Statement > income Tax Expense
-167895
Annuals > 0 > income Statement > EBITDA
-16145000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-2144000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
4710642
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
0
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
5680405
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
5680405
Annuals > 0 > balance Sheet > payables
830233
Annuals > 0 > balance Sheet > short Term Debt
499999999
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
2295332
Annuals > 0 > balance Sheet > equity
3385073
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-18289725
Annuals > 0 > cash Flow > depreciation
2135000
Annuals > 0 > cash Flow > change In Working Capital
333849
Annuals > 0 > cash Flow > cash From Operations
-10768504
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
13577259
Annuals > 0 > cash Flow > net Change In Cash
2808755
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-10.999551959201224
Annuals > 0 > ratios > PB
0.000049121392655343034
Annuals > 0 > ratios > ROE
-540.3133108207711
Annuals > 0 > ratios > ROA
-321.984083881343
Annuals > 0 > ratios > FCF
-10768504
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
29
Annuals > 1 > quarter
2022-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
10604000
Annuals > 1 > income Statement > operating Income
-10604000
Annuals > 1 > income Statement > interest Expense
5237
Annuals > 1 > income Statement > pretax Income
-14802000
Annuals > 1 > income Statement > net Income
-14802000
Annuals > 1 > income Statement > eps
-28.785568710425192
Annuals > 1 > income Statement > dividends Per Share
35000
Annuals > 1 > income Statement > shares Outstanding
514216
Annuals > 1 > income Statement > income Tax Expense
4192000
Annuals > 1 > income Statement > EBITDA
-16508000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-4197337
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
1901887
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
0
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
2204318
Annuals > 1 > balance Sheet > property Plant Equipment
-
Annuals > 1 > balance Sheet > total Assets
2204318
Annuals > 1 > balance Sheet > payables
721955
Annuals > 1 > balance Sheet > short Term Debt
173543
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
2095518
Annuals > 1 > balance Sheet > equity
108800
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-14801767
Annuals > 1 > cash Flow > depreciation
-5904000
Annuals > 1 > cash Flow > change In Working Capital
50348
Annuals > 1 > cash Flow > cash From Operations
-6071183
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
7528983
Annuals > 1 > cash Flow > net Change In Cash
1457800
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-28.785568710425192
Annuals > 1 > ratios > PB
0.000472625
Annuals > 1 > ratios > ROE
-13604.779411764706
Annuals > 1 > ratios > ROA
-671.5002100422897
Annuals > 1 > ratios > FCF
-6071183
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
16
Annuals > 2 > quarter
2021-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
7198000
Annuals > 2 > income Statement > operating Income
-7198000
Annuals > 2 > income Statement > interest Expense
2806000
Annuals > 2 > income Statement > pretax Income
-10229000
Annuals > 2 > income Statement > net Income
-13035000
Annuals > 2 > income Statement > eps
-18.811966922111097
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
692910
Annuals > 2 > income Statement > income Tax Expense
2806000
Annuals > 2 > income Statement > EBITDA
-7198000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-3031000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
444087
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
444087
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
648866
Annuals > 2 > balance Sheet > payables
736251
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
10757729
Annuals > 2 > balance Sheet > equity
-10108863
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-10228971
Annuals > 2 > cash Flow > depreciation
173353
Annuals > 2 > cash Flow > change In Working Capital
351726
Annuals > 2 > cash Flow > cash From Operations
-5512639
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
4833101
Annuals > 2 > cash Flow > net Change In Cash
-679538
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-18.811966922111097
Annuals > 2 > ratios > PB
-0.00000685448007357504
Annuals > 2 > ratios > ROE
128.9462524123633
Annuals > 2 > ratios > ROA
-2008.8893546587433
Annuals > 2 > ratios > FCF
-5512639
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
31
Annuals > 3 > quarter
2020-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
5566000
Annuals > 3 > income Statement > operating Income
-5566000
Annuals > 3 > income Statement > interest Expense
609458
Annuals > 3 > income Statement > pretax Income
-7826000
Annuals > 3 > income Statement > net Income
-8489000
Annuals > 3 > income Statement > eps
-14.407720324916243
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
589198
Annuals > 3 > income Statement > income Tax Expense
663000
Annuals > 3 > income Statement > EBITDA
-5619000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-2260000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
1123625
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
1123625
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
1123625
Annuals > 3 > balance Sheet > payables
346094
Annuals > 3 > balance Sheet > short Term Debt
611641
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
5752164
Annuals > 3 > balance Sheet > equity
-4628539
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-7826008
Annuals > 3 > cash Flow > depreciation
-53541
Annuals > 3 > cash Flow > change In Working Capital
961880
Annuals > 3 > cash Flow > cash From Operations
-2348822
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
3447500
Annuals > 3 > cash Flow > net Change In Cash
1098678
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-14.407720324916243
Annuals > 3 > ratios > PB
-0.000012729675606060574
Annuals > 3 > ratios > ROE
183.4056059590294
Annuals > 3 > ratios > ROA
-755.5011680943375
Annuals > 3 > ratios > FCF
-2348822
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.39158829676071055
Valuation > metrics > PB
-0.000423540345869154
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
165.85344264834424
Profitability > metrics > ROA
-374.93231083614404
Profitability > final Score
55
Profitability > verdict
Weak
Risk > final Score
50
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.3915625215770213
Liquidity > metrics > Quick Ratio
0.3915625215770213
Liquidity > final Score
30
Liquidity > verdict
Weak
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
50
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
55
Prev Risks > 0
50
Prev Risks > 1
46
Prev Risks > 2
-13308
Prev Liquidities > 0
100
Prev Liquidities > 1
50
Prev Liquidities > 2
75
Updated At
2026-01-20T22:26:51.428Z
Earnings History > 0 > period
2024-06-30
Earnings History > 0 > report Date
2024-09-20
Earnings History > 0 > date
2024-06-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
-0.39
Earnings History > 0 > eps Estimate
-0.3
Earnings History > 0 > eps Difference
-0.09
Earnings History > 0 > surprise Percent
-30
Earnings History > 1 > period
2024-03-31
Earnings History > 1 > report Date
2024-05-13
Earnings History > 1 > date
2024-03-31
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-0.5
Earnings History > 1 > eps Estimate
-0.43
Earnings History > 1 > eps Difference
-0.07
Earnings History > 1 > surprise Percent
-16.2791
Earnings History > 2 > period
2023-12-31
Earnings History > 2 > report Date
2024-03-11
Earnings History > 2 > date
2023-12-31
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-1.45
Earnings History > 2 > eps Estimate
-0.88
Earnings History > 2 > eps Difference
-0.57
Earnings History > 2 > surprise Percent
-64.7727
Earnings History > 3 > period
2023-09-30
Earnings History > 3 > report Date
2023-11-16
Earnings History > 3 > date
2023-09-30
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-5.1961
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2023-06-30
Earnings History > 4 > report Date
2023-08-30
Earnings History > 4 > date
2023-06-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-4.0402
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2023-03-31
Earnings History > 5 > report Date
2023-03-31
Earnings History > 5 > date
2023-03-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-5.1571
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2022-12-31
Earnings History > 6 > report Date
2023-03-30
Earnings History > 6 > date
2022-12-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.41
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2022-09-30
Earnings History > 7 > report Date
2022-11-14
Earnings History > 7 > date
2022-09-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.97
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2022-06-30
Earnings History > 8 > report Date
2022-08-29
Earnings History > 8 > date
2022-06-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
0.11
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
0.11
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2021-12-31
Earnings History > 9 > report Date
2022-01-04
Earnings History > 9 > date
2021-12-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.26
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.26
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2020-06-30
Earnings History > 10 > report Date
2020-07-02
Earnings History > 10 > date
2020-06-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.06
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.06
Earnings History > 10 > surprise Percent
-
PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies for the treatment of disorders with intractable neurologic symptoms. Its lead product candidate is PAX-101 that is in Phase 3 clinical trials, an intravenous formulation of suramin for the treatment of autism spectrum disorder, myalgic encephalomyelitis/chronic fatigue syndrome, long COVID-19 syndrome, fragile X syndrome, human African trypanosomiasis (HAT), and fragile X-associated tremor/ataxia syndrome. The company is developing PAX-102, an intranasal formulation of suramin for neurologic indications, as well as other new chemical entities that are targeted and selective antagonists of purine receptor subtypes; and PAX-HAT-301 for the treatment of HAT. It has a research collaboration agreement with PolarMar Health for Phase II clinical trial in austism spectrum disorder for emodin, which retains the rights for PolarMar to develop and commercialize any non-prescription supplement form of the product, and for PaxMedica, Inc. to retain exclusive rights to develop and commercialize a highly purified form of emodin. The company was formerly known as Purinix Pharmaceuticals LLC and changed its name to PaxMedica, Inc. in April 2020. PaxMedica, Inc. was incorporated in 2018 and is based in Tarrytown, New York.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AMorphoSys (NASDAQ:MOR) vs. PaxMedica (NASDAQ:PXMD) Head to Head Comparison Defense World
Read more →Showing 2 of 9
(Last Updated 2024-06-30)
Rating:
BUY
Target Price:
$3
Analyst Picks
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2024-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 1.64% of the total shares of PaxMedica, Inc. Common Stock
1.
Souders Financial Advisors(0.5141%)
since
2024/03/31
2.
Virtu Financial LLC(0.4796%)
since
2024/03/31
3.
Susquehanna International Group, LLP(0.3354%)
since
2024/03/31
4.
TWO SIGMA SECURITIES, LLC(0.212%)
since
2024/03/31
5.
Tower Research Capital LLC(0.0903%)
since
2024/03/31
6.
Northern Trust Extended Eq Market Idx(0.0024%)
since
2024/03/31
7.
Advisor Group Holdings, Inc.(0.0008%)
since
2024/03/31
8.
Wells Fargo & Co(0.0004%)
since
2024/03/31
9.
NT Ext Eq Mkt Indx Fd DC Lending Tier 5(0.0001%)
since
2024/03/31
10.
Hartland & Co(0%)
since
2024/03/31
11.
JPMorgan Chase & Co(0%)
since
2024/03/31
12.
UBS Group AG(0%)
since
2024/03/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2024-06-30
EPS Actual
-0.39
EPS Estimate
-0.3
EPS Difference
-0.09
Surprise Percent
-30%
(Last Updated 2024-06-30)
(Last Updated 2024-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2024-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2024-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.